[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368045-105":59,"doc-detail-368045-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","increased-incidence-survival-and-registration-quality-of-primary-hepato-pancreato-biliary-cancers-in-the-netherlands-cancer-registry","Increased incidence, survival, and registration quality of primary hepato-pancreato-biliary cancers in the Netherlands Cancer Registry","","Given the poor survival and relatively poor data quality performance of hepato-pancreato-biliary (HPB) cancers in cancer registries, this study assesses trends in incidence, survival, and data quality within the Netherlands Cancer Registry. Primary solid liver, gallbladder, biliary tract, and pancreatic cancers diagnosed between 1989 and 2022 were included (n=109,552). Incidence and mortality used revised European age-standardised rates, while survival used age-standardised 5-year relative survival (AS-5yRS).",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/increased-incidence-survival-and-registration-quality-of-primary-hepato-pancreato-biliary-cancers-in-the-netherlands-cancer-registry/368045/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/increased-incidence-survival-and-registration-quality-of-primary-hepato-pancreato-biliary-cancers-in-the-netherlands-cancer-registry/368045.png","ImageObject",300,407,{"name":92,"@type":93},"hdkawk","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-19","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":56},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Which cancers and years were included in the analysis?","Question",{"text":112,"@type":113},"Primary solid liver, gallbladder, biliary tract, and pancreatic cancers diagnosed between 1989 and 2022 were included, totaling 109,552 cases.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were incidence, mortality, and survival outcomes calculated?",{"text":117,"@type":113},"Revised European age-standardised rates were calculated for incidence and mortality, while survival used age-standardised 5-year relative survival (AS-5yRS).",{"name":119,"@type":110,"acceptedAnswer":120},"What overall trends were observed for incidence and survival over time?",{"text":121,"@type":113},"Both incidence and survival rates of primary HPB cancers increased over time, while gallbladder survival gains later stagnated after 2010.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368045,1790283337,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":56,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},3985747859855,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","DOI: 10.1002/ijc.70145  \nRES EARCH A RTICLE  \nCa ncer Epidemiology  \nIncreased incidence, survival, and registration quality of primary hepato-pancreato-biliary cancers in the Netherlands Cancer Registry  \nLydia G. van der Geest 1,2  | Marianne van der Mark 1 | Joanne Verheij 3 | Arantza Farina Sarasqueta 3 | Judith de Vos-Geelen 4,5  | Marc G. Besselink 6,7 | Vincent E. de Meijer 8 | Ignace H. J. T. de Hingh 5,9 | Bert A. Bonsing 10 |  \nPhilip R. de Reuver 11 | Francois E. J. A. Willemssen 12 | Pauline A. J. Vissers 1,11  | Otto Visser 13 | the Dutch Pancreatic Cancer Group and the Dutch  \nHepatocellular & Cholangiocarcinoma Group  \n1Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands 2Department of Medical Oncology, Amsterdam UMC, Location University of Amsterdam, Amsterdam, The Netherlands 3Department of Pathology, Amsterdam UMC, Location University of Amsterdam, Amsterdam, The Netherlands  \n4Division of Medical Oncology, Maastricht University Medical Center, Maastricht, The Netherlands  \n5GROW—Research Institute for Oncology & Reproduction, Maastricht University Medical Center, Maastricht, The Netherlands 6Department of Surgery, Amsterdam UMC, Location University of Amsterdam, Amsterdam, The Netherlands  \n7Treatment and Quality of Life, Cancer Center Amsterdam, Amsterdam, The Netherlands  \n8Department of Surgery, University of Groningen and University Medical Center Groningen, Groningen, The Netherlands 9Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands  \n10Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands  \n11Department of Surgery, Radboud University Medical Center, Nijmegen, The Netherlands  \n12Department of Radiology and Nuclear Medicine, Erasmus Medical Center, Rotterdam, The Netherlands 13Department of Registration, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands  \nCorrespondence  \nLydia G. van der Geest, Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), P.O. Box 19 079, 3501 DB Utrecht, The Netherlands.  \nEmail: l.vandergeest@iknl. nl  \nAbstract  \nGiven the poor survival and relatively poor performance of hepato-pancreato-biliary (HPB) cancers on data quality indicators for cancer registries, we assessed trends in incidence, survival, and data quality of HPB cancers within the Netherlands Cancer Registry (NCR) . All primary solid liver, gallbladder, biliary tract, and pancreatic cancers  \nAbbreviations: 5yRS, 5-year relative survival (not age-standardised); AAPC, average annual percent change; AS-5yRS, age-standardised 5-year relative survival; CBG, Central Bureau for Genealogy [in Dutch: Centraal Bureau Genealogie]; CI, confidence interval (95%); CRs, cancer registries; DCN, death certificate notification; DCO, Death Certificate Only; ECIS, European Cancer Information System; EoD, extent-of-disease (1 digit); HPB, hepato-pancreato-biliary; ICD10, International Classification of Diseases tenth edition; ICD-O-3, International Classification of Diseases for Oncology third edition; LBZ, National Hospital Care Registration [in Dutch: Landelijke Basisadministratie Ziekenhuiszorg]; LMR, National Registry of Hospital Discharges [in Dutch:  \nLandelijke Medische Registratie]; M0, locoregional or non-metastatic disease; M1, distant metastasis; M:I ratio, Mortality-to-Incidence ratio; NCR, Netherlands Cancer Registry; Palga (previously PALGA), National Pathological Archives [in Dutch: Pathologisch-Anatomisch Landelijk Geautomatiseerd Archief]; rESR, revised European Age-Standardised Rates (for incidence and mortality); SN, Statistics Netherlands; TDT, tumour-directed treatment; TNM, Tumour-Node-Metastasis classification (3 parts combined to 1 tumour stage); UICC, Union for International Cancer Control.  \nThis is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and","cbCaifKT04rNBNeb","https://ap.wps.com/l/cbCaifKT04rNBNeb","pdf",5081860,13,"English","# Abstract\n## Study design and dataset\n## Measures and calculations\n## Incidence trends\n## Survival and mortality trends\n## Data quality findings","[{\"question\":\"Which cancers and years were included in the analysis?\",\"answer\":\"Primary solid liver, gallbladder, biliary tract, and pancreatic cancers diagnosed between 1989 and 2022 were included, totaling 109,552 cases.\"},{\"question\":\"How were incidence, mortality, and survival outcomes calculated?\",\"answer\":\"Revised European age-standardised rates were calculated for incidence and mortality, while survival used age-standardised 5-year relative survival (AS-5yRS).\"},{\"question\":\"What overall trends were observed for incidence and survival over time?\",\"answer\":\"Both incidence and survival rates of primary HPB cancers increased over time, while gallbladder survival gains later stagnated after 2010.\"}]","Increased incidence, survival, and registration quality of primary hepato-pancreato-biliary cancers in the Netherlands Cancer Registry | PDF",1790174617,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/75345f3f7b7bd4f79ed6aeeb194b35f2.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3b07819592a828ab6999f2f1e239f1e0.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4895d369921c0f3b5c8c728ef4c4c517.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/63a5274dba9a2ab69f05ffff89c81252.webp",980,1287]